-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Johnson & Johnson, Lowers Price Target to $292

Benzinga·10/15/2026 16:52:33
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and lowers the price target from $294 to $292.